Management of Persistent Low Libido Despite Bupropion Addition
You should switch from escitalopram to bupropion monotherapy rather than continuing the combination, as bupropion has significantly lower sexual dysfunction rates (8-10%) compared to escitalopram, and the SSRI is likely the primary driver of the persistent libido problem. 1, 2
Why the Current Strategy Is Failing
- Escitalopram, like all SSRIs, causes sexual dysfunction through multiple mechanisms including decreased libido, delayed orgasm, and reduced genital sensation, with real-world rates substantially higher than reported in trials 1
- Adding bupropion 300 mg to an SSRI addresses only part of the problem—the SSRI continues to actively suppress sexual function even with bupropion augmentation 3, 4
- The evidence for bupropion as an "antidote" when added to ongoing SSRIs is mixed: one open-label study showed 46-75% response rates 3, but a placebo-controlled trial found bupropion SR 150 mg daily was no better than placebo for SSRI-induced sexual dysfunction 5
Recommended Treatment Algorithm
Step 1: Switch to Bupropion Monotherapy
- Discontinue escitalopram gradually (taper over 10-14 days to limit withdrawal symptoms) while simultaneously starting or continuing bupropion 1
- Target bupropion dose: 300-400 mg/day for optimal antidepressant efficacy, as 150 mg daily has shown insufficient benefit in controlled trials 2, 5
- Bupropion demonstrates comparable antidepressant efficacy to SSRIs but with dramatically lower sexual dysfunction rates (8-10% vs. 40-70% for SSRIs) 1, 2, 6
Step 2: Monitor Response Within 2-4 Weeks
- Most improvement in sexual function occurs within the first 2 weeks of bupropion treatment at doses of 100-200 mg/day, with further benefit at higher doses 3
- Assess both depressive symptoms and sexual function (libido, arousal, orgasm) at 1-2 weeks and again at 6-8 weeks 1, 2
Step 3: If Depression Control Is Inadequate on Bupropion Alone
- Consider mirtazapine 15-30 mg/day as an alternative, which has lower sexual dysfunction rates than SSRIs but causes sedation and weight gain 1
- If an SSRI must be used due to comorbid anxiety, avoid paroxetine entirely (70.7% sexual dysfunction rate) and consider sertraline or citalopram as less problematic options 1, 2
Critical Safety Considerations
- Bupropion increases seizure risk, particularly at doses >300 mg/day or in patients with eating disorders, history of seizures, or abrupt alcohol/benzodiazepine discontinuation 2, 6
- Do not use bupropion in agitated patients or those with seizure disorders 1
- Monitor for discontinuation symptoms when tapering escitalopram, including dizziness, paresthesias, anxiety, and flu-like symptoms 2
Adjunctive Strategies If Switching Is Not Feasible
If the patient cannot discontinue escitalopram due to superior depression/anxiety control:
- Add a PDE5 inhibitor (sildenafil or tadalafil) if erectile dysfunction coexists with low libido, though these primarily address erectile function rather than desire 1, 2
- Check morning testosterone levels (target >300 ng/dL), as low testosterone contributes to decreased libido independent of SSRI effects 1
- Consider non-pharmacologic interventions: vibratory therapy for loss of genital sensation, pelvic physical therapy for co-existing pelvic floor dysfunction, and sex therapy or couples counseling 1
Common Pitfalls to Avoid
- Do not use buspirone—despite its mention in some guidelines, the American College of Physicians explicitly recommends against it for SSRI-induced sexual dysfunction due to lack of evidence 1
- Do not assume the current dose of bupropion is adequate—the failed placebo-controlled trial used only 150 mg daily, and higher doses (300-400 mg) may be necessary 5, 2
- Do not underestimate the persistence of SSRI effects—sexual dysfunction from SSRIs is dose-related and will continue as long as the SSRI is maintained, regardless of augmentation strategies 1